HEИндивидуална стипендия2026–2028

MAGMAbots · MAGnetic hyperthermia agents based on Magnetically Activated microroBOTS.

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2026-08-01 → 2028-07-31
Финансиране от ЕС
209 483 €
Участници
1
Схема
HORIZON-TMA-MSCA-PF-EF

Линиите свързват координатора с партньорите.

Накратко на български

Магнитни микророботи, създадени от бактерии и имунни клетки, се тестват за унищожаване на тумори чрез локално загряване. Тези технологии помагат за разработването на по-ефективни и неинвазивни методи за терапия при трудно лечими видове рак.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Цел на проекта

The MAGMAbots project proposes the development of three innovative magnetically actuated microrobots (MAMs)—based on magnetic nanoparticles (MNP)-loaded neutrophils, probiotic bacteria, and magnetotactic bacteria—for cancer therapy through magnetic hyperthermia (MHT) and advanced imaging. The objectives are: (1) to design and characterize neu-MAGMAbot, an MAM based on neutrophils, evaluating its penetration across a 3D blood–brain barrier (BBB) model and its anticancer activity against glioblastoma; (2) to engineer pro-MAGMAbot, a probiotic-based microrobot, and test its targeting, cytotoxicity, and hyperthermia performance in colorectal cancer spheroids; and (3) to develop mag-MAGMAbot, MAMs based on magnetotactic bacteria with enhanced magnetosome-based magnetic and diagnostic properties.The project will achieve these objectives based on a patented-driven methodology. This strategy preserves cell viability while enabling robust MNP internalization, and subsequent magnetic guidance via rotating magnetic fields, and real-time tracking through MPI/MRI. The work plan integrates advanced nanoparticle engineering, microfluidic BBB-on-chip models, 3D cancer spheroids, and multimodal imaging technologies, supported by the host group’s expertise in nanomaterials, magnetism, and biomedical applications.Aligned with Horizon Europe’s Health Cluster and the Mission on Cancer, MAGMAbots directly addresses the challenge of developing innovative, non-invasive, and cost-effective therapeutic solutions for hard-to-treat tumours such as glioblastoma and colorectal cancer. Beyond the project’s duration, the results are expected to pave the way for scalable, patentable biohybrid microrobots, reduce healthcare costs, and reinforce European leadership in nanomedicine and biomedical innovation.

Оригинален текст от CORDIS (на английски).

Участници

  • FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA · GenovaКоординаторИталия

Връзки

Данни: CORDIS, © Европейски съюз